Poster Session
Issue Date: August 2020
Published Online: August 01, 2020
Updated: July 29, 2020
Assessment of Cancer-Related Cognitive Decline (CRCD) and Related Factors in an Inpatient Oncology Population
Author Affiliations & Notes
  • Good Shepherd Penn Partners, Philadelphia, PA, USA
  • Good Shepherd Penn Partners, Philadelphia, PA, USA
Article Information
Health and Wellness / Mental Health / Musculoskeletal Impairments / Vision / Assessment/Measurement
Poster Session   |   August 01, 2020
Assessment of Cancer-Related Cognitive Decline (CRCD) and Related Factors in an Inpatient Oncology Population
American Journal of Occupational Therapy, August 2020, Vol. 74, 7411500028. https://doi.org/10.5014/ajot.2020.74S1-PO5724
American Journal of Occupational Therapy, August 2020, Vol. 74, 7411500028. https://doi.org/10.5014/ajot.2020.74S1-PO5724
Abstract

Date Presented 03/27/20

Cancer-related cognitive decline is not well understood in the oncology population, and evaluation for cognitive dysfunction while inpatient is not routine. The aims of this project are to: (1) identify the prevalence of CRCD in an inpatient hospital utilizing the Trail Making Test Part B, and (2) identify differences between individuals experiencing CRCD and those scoring within normal limits.

Primary Author and Speaker: Erika Dobson

Additional Authors and Speakers: Malarie Molinari